How to Manage a Melanoma-like Advanced NSCLC with BRAF V600E in an Elderly Patient
Microlearning | English | 2025 | 15 Min
Image For Activity Cover
Availability
On-Demand
Cost
$0.00
Credit Offered
No Credit Offered
This microlearning case study from the 2024 Amazing Case Race focuses on the management of a patient with BRAF p.V600E mutant NSCLC with metastatic skin lesions. The activity focuses on developing a comprehensive histological and molecular diagnosis, assessing differential diagnosis, and managing effective treatment in elderly and frail patients. 
This activity is designed to meet the educational needs of researchers and healthcare professionals who diagnose and treat patients with lung cancer including medical oncologists, thoracic surgeons, radiation oncologists, radiologists, pathologists, advanced practice nurses and physician associates.
Upon completion of this activity, the participants should be able to: 
  • Develop a comprehensive histological and molecular diagnosis.
  • Assess differential diagnosis.
  • Manage effective treatment in elderly and frail patients.
  • Lorenzo Belluomini, MD, PhD, Verona, Italy
The information presented is that of the contributing faculty and does not necessarily represent the views of the International Association for the Study of Lung Cancer and/or any named commercial entity providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty presenters. Therefore, before prescribing any medication, please review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse effects.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
If you need any assistance with this activity, please email: education@iaslc.org.
Powered By